To access this element change to forms mode OFF
Grant Award View - GA299376
Precison Oncology Screening Platform enabling Clinical Trials ...
GA ID:
GA299376
Agency:
Department of Industry, Science and Resources
Approval Date:
27-Feb-2022
Publish Date:
2-May-2023
Category:
Industry Innovation
Grant Term:
28-Apr-2023 to 29-Jul-2026
Value (AUD):
$67,300,200.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 22/23 Growing innovative & competitive bus, industries & regions
Grant Program:
Modern Manufacturing Initiative
Grant Activity:
Precison Oncology Screening Platform enabling Clinical Trials (PrOSPeCT)
Purpose:
Omico (Australian Genomic Cancer Medicine Centre) will establish and operate PrOSPeCT - a Precision Oncology Screening Platform enabling Clinical Trials. The project will provide access to genomic screening for more than 20,000 Australian advanced and incurable cancer patients and the creation and commercialisation of a real-world dataset of international significance from the resulting screening data.
The large scale genomic screening of cancer patients is expected to grow industry-sponsored clinical trials activity in Australia by identifying cohorts of patients suitable for clinical trials across a range of cancers. Pharmaceutical and data analytics companies will be charged a subscription fee to access the screening data which they can use in clinical trials and drug development.
The project is designed as a public-private consortium, consisting of Omico, Commonwealth and NSW governments, the National Computational Infrastructure, Roche Australia and The Childrens Cancer Institute of Australia, as well as more than 15 small, medium and large businesses across hospital networks/healthcare providers, biotechnology and pharmaceutical companies, contract research and manufacturing organisations, medical research institutes, investment organisations and data and analytics providers.
GO ID:
GO Title:
Modern Manufacturing Initiative – Manufacturing Collaboration stream
Internal Reference ID:
MMIMCS000002
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
AUSTRALIAN GENOMIC CANCER MEDICINE CENTRE LTD
Recipient ABN:
67 627 640 733
Grant Recipient Location
Suburb:
DARLINGHURST
Town/City:
DARLINGHURST
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
2010
Country:
AUSTRALIA